Bailard »

Eton Pharmaceuticals shares owned by Bailard

Quarter-by-quarter ownership of Eton Pharmaceuticals (ETON) shares owned by Bailard from 13F filings

Historical chart of Bailard investment in Eton Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Eton Pharmaceuticals held by Bailard consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Eton Pharmaceuticals by Bailard

Quarter filed Position value Share count Share price at filing
2023-12-31 $99k 23k 4.38
2023-06-30 $44k 13k 3.49

More positions owned by Bailard

Microsoft Corporation (MSFT)
Apple (AAPL)
Invesco Qqq Tr Unit Ser 1 (QQQ)
Spdr S&p 500 Etf Tr Tr Unit (SPY)
Ishares Tr Msci Eafe Etf (EFA)
Alphabet Cap Stk Cl A (GOOGL)
Ishares Tr Rus 2000 Val Etf (IWN)
NVIDIA Corporation (NVDA)
Ishares Tr Core Msci Eafe (IEFA)
Vanguard Index Fds Total Stk Mkt (VTI)
Vanguard World Inf Tech Etf (VGT)
Janus Detroit Str Tr Henderson Mtg (JMBS)
Gilead Sciences (GILD)
Amazon (AMZN)
Visa Com Cl A (V)

View all positions for Bailard

Top funds holding Eton Pharmaceuticals

Opaleye Management
Vanguard Group
Acuitas Investments
Westside Investment Management
BlackRock
Susquehanna International
Acadian Asset Management
Essex Investment Management
Bank of New York Mellon
Squarepoint Ops
Schonfeld Strategic Advisors
Two Sigma Investments
Connor, Clark & Lunn Investment Management
William Blair $ Company
Bank Of Montreal

View all funds holding Eton Pharmaceuticals